chrX-48966157-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004979.6(KCND1):c.1616G>A(p.Arg539His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000446 in 1,209,422 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000027 ( 0 hom., 0 hem., cov: 24)
Exomes 𝑓: 0.000047 ( 0 hom. 14 hem. )
Consequence
KCND1
NM_004979.6 missense
NM_004979.6 missense
Scores
2
8
7
Clinical Significance
Conservation
PhyloP100: 3.07
Genes affected
KCND1 (HGNC:6237): (potassium voltage-gated channel subfamily D member 1) This gene encodes a multipass membrane protein that comprises the pore subunit of the voltage-gated A-type potassium channel, which functions in the repolarization of membrane action potentials. Activity of voltage-gated potassium channels is important in a number of physiological processes, among them the regulation of neurotransmitter release, heart rate, insulin secretion, and smooth muscle contraction. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.24455178).
BS2
High Hemizygotes in GnomAdExome4 at 14 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCND1 | NM_004979.6 | c.1616G>A | p.Arg539His | missense_variant | 5/6 | ENST00000218176.4 | NP_004970.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCND1 | ENST00000218176.4 | c.1616G>A | p.Arg539His | missense_variant | 5/6 | 1 | NM_004979.6 | ENSP00000218176.3 | ||
KCND1 | ENST00000376477.5 | c.485G>A | p.Arg162His | missense_variant | 4/5 | 2 | ENSP00000365660.1 | |||
KCND1 | ENST00000419374.1 | c.329G>A | p.Arg110His | missense_variant | 2/2 | 3 | ENSP00000413989.1 |
Frequencies
GnomAD3 genomes AF: 0.0000265 AC: 3AN: 113128Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35258
GnomAD3 genomes
AF:
AC:
3
AN:
113128
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
35258
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000224 AC: 4AN: 178907Hom.: 0 AF XY: 0.0000155 AC XY: 1AN XY: 64619
GnomAD3 exomes
AF:
AC:
4
AN:
178907
Hom.:
AF XY:
AC XY:
1
AN XY:
64619
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000465 AC: 51AN: 1096294Hom.: 0 Cov.: 31 AF XY: 0.0000386 AC XY: 14AN XY: 362402
GnomAD4 exome
AF:
AC:
51
AN:
1096294
Hom.:
Cov.:
31
AF XY:
AC XY:
14
AN XY:
362402
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000265 AC: 3AN: 113128Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35258
GnomAD4 genome
AF:
AC:
3
AN:
113128
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
35258
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.1616G>A (p.R539H) alteration is located in exon 5 (coding exon 5) of the KCND1 gene. This alteration results from a G to A substitution at nucleotide position 1616, causing the arginine (R) at amino acid position 539 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Pathogenic
DEOGEN2
Uncertain
.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
.;M
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
0.13
.;B
Vest4
MutPred
0.30
.;Loss of methylation at K538 (P = 0.0496);
MVP
MPC
0.31
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at